All News

The White House nominates Robert Califf to once again take the reins of FDA, but acting commissioner Janet Woodcock will remain in place during the Senate confirmation process.

Recognizing leadership in pharma.

Merck and Ridgeback Biotherapeutics’ anti-viral pill is reported to halve the risk of hospitalization or death.

Solution leverages AI and natural language processing to accelerate and improve the review of materials used to market pharmaceutical and medical device products.

Carlyle and co-investors including Amgen Ventures, Merck Global Health Innovation Fund, Pfizer Ventures, and Population Health Partners to acquire majority stake in Saama Technologies.

Stay-at-home orders during the pandemic forced a shift in patient preferences—and the pharma industry has responded.

Rebrand launched to design, develop, and deliver specialist training, skills assessments and process consultancy to the healthcare and pharma industries.

PharmaLex has announced the launch of a new service line, Biopharma Excellence, and appointed a new Chief Medical Officer.

With the headlines focused on COVID-19, many may have forgotten about the escalating epidemic of substance use disorder. National Recovery Month is a time to bring this issue back to the top of the agenda, raise awareness, and drive action, writes Richard Pops, CEO of Alkermes.

At this point of the evolving RWD landscape, we thought it appropriate to begin to broadly assess the use of real world data.

OM Pharma, active in the prevention of recurrent respiratory and urinary tract infections, wins the 2021 Geneva Economy Award.

Renowned clinician, scientist and proven executive leader in biotechnology and healthcare with more than 25 years’ experience developing life-changing cellular medicines.

Coupled with broader migration trends happening in the US, new upstart locations become increasingly attractive for investors, developers, tenants, and landlords.

Merck and Otsuka recognized for driving greater equality for women in the workplace.

FDA is launching a program to test the safety and suitability of novel inactive ingredients for use in new drugs and biologics.

17 abstracts highlighting safety and efficacy to be shared at upcoming conference.

Medical Information (MI) Contact Center services now deploy AI-powered virtual agents alongside skilled human agents to triage and respond to inquiries.

Funding will be used to further develop CC Bio’s microbiome editing technologies, which harness potent enzymes derived from bacterial viruses to seek out and destroy harmful and disease-causing bacteria.

Partnership pairs Aktana’s Contextual Intelligence Engine with Real Chemistry’s data and creative campaign.

“Future Innovator Prize” sponsorship provides access to life-science incubator and in-house Astellas expertise for scientific entrepreneurs with cutting-edge ideas

Laura Steele will lead Lilly’s commercial business operations in six countries, across the company’s current and emerging portfolio in Diabetes, Oncology, Immunology and Neuroscience.

What can both public and private sector stakeholders learn from current trends to accelerate innovation around the COVID-19 pandemic and other emerging global health threats, including antimicrobial resistance?

New findings detail how executives handle compliance challenges.

Will oversee global acceleration and scaling of ZS’ portfolio of life sciences and healthcare work.

Novartis and the Novartis US Foundation have launched a 10-year commitment to co-create programs “that address the root causes of systemic disparities in health outcomes and create greater diversity, equity and inclusion across the research and development ecosystem.”

ProductLife Group has announced its acquisition of Czech Republic-based global regulatory outsourcing company, ELC Group.

Transaction with special purpose acquisition company totals $138 million.

New cell and gene therapy commercialization network set to support small and midsize biotechs.

Latest release will provide biopharma and medical device companies greater commercial success.